(Optical Research for Biopsy Triaging)​

DynamX Medical have recently completed a Phase 2 in-clinic trial on oesophageal cancer and colon cancer.  This trial was performed at four independent sites across the UK.  

400 patient in-clinic trial, deploying the system bedside at 4 NHS endoscopy units, enabling us to validate clinical performance and ensure seamless integration with established clinical workflows.

System usability was tested over a wide range of users including research nurses, endoscopists and health care assistants.

Initial analysis of the study data shows improved performance over the previous Phase 1 clinical trial, enabling significant reduction in the workload for pathology services and expansion of screening programmes.

Find out more

Follow the links below to find out more about DynamX Medical and our other clinical trials 

© 2019 DynamX Medical is the trading name of BeamLine Diagnostics Ltd.
Registered in England & Wales Number 09504725.
Rutherford Appleton Laboratories, Building R103 Office R-103, Harwell Campus, Didcot, OX11 0QX
Icons made by Freepik from www.flaticon.com